Page
%P
-
Article
Open AccessVorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
Vorinostat, a histone deacetylase (HDAC) inhibitor, is a promising agent for cancer therapy. Combining vorinostat with cisplatin may relax the chromatin structure and facilitate the accessibility of cisplatin,...